UK markets closed

Abingdon Health Plc (ABDXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.07000.0000 (0.00%)
At close: 09:32AM EDT

Abingdon Health Plc

York Biotech Campus
Sand Hutton
York YO41 1LZ
United Kingdom
44 19 0440 6050

IndustryDiagnostics & Research
Full-time employees74

Key executives

NameTitlePayExercisedYear born
Mr. Chris Henry Francis YatesCEO & Director274.95kN/A1974
Ms. Melanie RossCFO, Company Sec. & Director205.59kN/A1980
Mr. Mark JonesChief Operating OfficerN/AN/AN/A
Ms. Brenda HoganHR DirectorN/AN/AN/A
Mr. Oliver GardnerChief Commercial OfficerN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices worldwide. The company offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; PCRD and PCRD FLEX, nucleic acid lateral flow tests used for rapid readouts post isothermal amplification; Abingdon Simply Test, a range of self-tests; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2. It also provides AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Corporate governance

Abingdon Health Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.